Lilly sets date for move from Faris campus downtown
Work force reductions, new business structure make leased office space unnecessary. Moves will begin in late June.
Health Care & Life Sciences
Articles
Lilly diabetes drug may have cancer risk, FDA says
Once-weekly form of Byetta is awaiting the FDA’s OK. Analyst predict the new version of the drug, if approved, could rack
up sales of $2 billion annually.
Nursing home association facing big debt
The Indiana Health Care Association is looking for a new leader even as it tries to dig out of a pile
of debt. Current President Steve Smith, whose contract expires Nov. 30, says he’s put the organization on a path to be financially stable by 2012. But his predecessor says Smith has ruined a once-strong organization.
Louisiana gets $20M in Lilly drug settlement
Louisiana was one of 13 states that filed individual suits in state courts over allegations that Lilly pushed Zyprexa for
uses that had not been approved by federal regulators.
Members: Anthem health plans subpar
Anthem Blue Cross and Blue Shield of Indiana fell slightly below average for customer satisfaction among scores of health
plans,
according to a new survey by California-based J.D. Power & Associates.
Medical oxygen plant in Plainfield closing; 130 to lose jobs
Relocating operations to an existing plant in Canton, Ga., will result in the loss of 130 jobs.
Hospitals stand to gain big by hiring docs
To understand why hospitals are so eager to employ physicians—and prevent them from owning their own facilities—look
no further than the latest data on how much doctors are paid compared with how much revenue they generate for hospitals.
Shareholder group wants WellPoint to become not-for-profit
Proposal at annual meeting will ask health insurer to study feasibility of converting to not-for-profit status.
Conseco trims CEO’s pay but gives exec team raises
James Prieur’s total compensation fell 5 percent last year to $3.3 million, but other Conseco executives saw pay hikes between
25 percent and 54 percent.
IU study suggests that money does matter to doctors
Patients seen at private facilities reimbursed by Medicare were 5-1/2 times more likely to receive routine cataract surgery
than patients at Veterans Affairs facilities, according to a new study.
Lilly wins court ban on generic copy of Gemzar
Eli Lilly and Co. won a U.S. court ruling Wednesday that bars Teva Pharmaceutical Industries Ltd. from selling a generic version
of the cancer drug Gemzar until November.
Lilly drug wins U.K. backing as cancer therapy
Eli Lilly and Co.’s Alimta has received the preliminary backing of a United Kingdom agency as a maintenance treatment for
patients with the most common form of lung cancer.
Hill-Rom to cut 160 more jobs
The Batesville-based medical equipment supplier said it expects the cuts to save the company about $16 million a year.
Spine center offering quick care for pain
An Indianapolis doctors' office has started an offshoot practice that specializes in quickly seeing patients with severe
back pain.
Volunteers in Medicine fill need as boomers retire
Not-for-profit sees increasing numbers of patients, but can't plug the entire gap to be created by health care retirements.
Daniels one of health law’s loudest critics
Indiana Gov. Mitch Daniels is fast becoming critic-in-chief of the health reform law.
WellPoint faces biggest changes under new law
The Indianapolis-based health insurer has more individual and small-business customers than its major competitors, increasing
the impact of health reform.
Indiana joins legal challenge to health care overhaul
State attorney general says the federal health care law raises serious constitutional questions, including whether Congress
has the authority to enact a mandate that most Americans purchase health insurance.
Eli Lilly spent $2.2 M lobbying in 4th quarter
Lilly’s lobbying spending represents a 36-percent drop from the final quarter of 2008, even though the Congressional debate
over health care reform peaked during the last quarter of 2009.